Acurx Pharmaceuticals, Inc. (ACXP) Form 10-K Annual Reports
Acurx Pharmaceuticals, Inc. (ACXP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ACXP
CIK: 1736243
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CohnReznick LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerRavi Raghunathan
Audit LocationParsippany, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-16 | FORM 8-K | 0001104659-26-116632 | View SEC Doc Filr Page |
| EFFECT | 2026-09-17 | — | EFFECT Filing | 9999999995-26-003000 | View SEC Doc Filr Page |
| 424B3 | 2026-09-17 | — | 424B3 | 0001104659-26-108599 | View SEC Doc Filr Page |
| S-1 | 2026-09-08 | — | S-1 | 0001104659-26-105917 | View SEC Doc Filr Page |
| ARS | 2026-09-01 | 2025-12-31 | ARS | 0001104659-26-104320 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-01 | — | DEFA14A | 0001104659-26-104319 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-01 | 2026-10-16 | DEF 14A | 0001104659-26-104316 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001104659-26-095904 | View SEC Doc Filr Page |
| 424B3 | 2026-05-12 | — | 424B3 | 0001104659-26-059298 | View SEC Doc Filr Page |
| 424B3 | 2026-05-12 | — | 424B3 | 0001104659-26-059296 | View SEC Doc Filr Page |
| EFFECT | 2026-05-11 | — | EFFECT Filing | 9999999995-26-001578 | View SEC Doc Filr Page |
| EFFECT | 2026-05-11 | — | EFFECT Filing | 9999999995-26-001577 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001104659-26-058631 | View SEC Doc Filr Page |
| CORRESP | 2026-05-07 | — | CORRESP Filing | 0001104659-26-057279 | View SEC Doc Filr Page |
| CORRESP | 2026-05-07 | — | CORRESP Filing | 0001104659-26-057277 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-07 | — | UPLOAD Filing | 0000000000-26-004693 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-07 | — | UPLOAD Filing | 0000000000-26-004692 | View SEC Doc Filr Page |
| S-1 | 2026-05-04 | — | FORM S-1 | 0001104659-26-054887 | View SEC Doc Filr Page |
| S-1 | 2026-05-04 | — | FORM S-1 | 0001104659-26-054884 | View SEC Doc Filr Page |
| D | 2026-04-29 | — | D Filing | 0001736243-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-20 | OWNERSHIP DOCUMENT | 0001104659-26-046846 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-20 | OWNERSHIP DOCUMENT | 0001104659-26-046844 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-20 | OWNERSHIP DOCUMENT | 0001104659-26-046842 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-20 | OWNERSHIP DOCUMENT | 0001104659-26-046840 | View SEC Doc Filr Page |
| 4 | 2026-04-22 | 2026-04-20 | OWNERSHIP DOCUMENT | 0001104659-26-046837 | View SEC Doc Filr Page |